Friday, December 14, 2012 3:59:04 PM
Gallagher went on to say, "While we experienced growing pains during the year that prevented us from fully reaching our goals, 2012 will be our third consecutive year of double digit top line growth and the best year our Company has ever had. We were also excited to have been approached by a $100 Million Company owned by a $20 Billion fund regarding a possible acquisition transaction at this stage of our development. While no deal we could accept materialized, we identified certain overlooked areas of opportunity during the process that we fully plan to exploit heading into 2013. With these talks now over and our fiscal year ending last week, we've refocused our efforts on completing our financial statements to remove the stop sign on OTC Markets.com as soon as possible and continue the process towards becoming a fully reporting Company in early 2013."
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM